CIRIMAT, UMR 5085 INPT-CNRS-UPS, Université de Toulouse, ENSIACET, 4 Allée Emile Monso, 31030 Toulouse, France.
CIRIMAT, UMR 5085 INPT-CNRS-UPS, Université de Toulouse, ENSIACET, 4 Allée Emile Monso, 31030 Toulouse, France.
Acta Biomater. 2016 Sep 1;41:320-7. doi: 10.1016/j.actbio.2016.05.030. Epub 2016 May 21.
The development of bioactive phosphate-based glasses is essential in biomaterials science, and especially for bone substitution applications. In this context, the preparation of amorphous calcium-phosphorus hydroxide/oxide monoliths at low temperature is a key challenge for being able to develop novel hybrid materials for these applications. We herein report for the first time the synthesis and physical chemical characterisation of a novel family of pyrophosphate-based glasses (with the formula: {[(Ca(2+))1-x(H(+)/K(+))2x]2[(P2O7(4-))1-y(PO4(3-))4y/3]} n(H2O)), which were prepared by soft chemistry using low temperatures (T<70°C) and water as a solvent. The effect of the initial Ca/Pyrophosphate ratio on the structure and morphology of these pyrophosphate glasses was investigated in detail. Depending on this ratio, a glass (mixed calcium pyro- and orthophosphate) or a glass-ceramic (Ca10K4(P2O7)6·9H2O crystals embedded in the amorphous phase) was obtained. The proportion of the crystalline phase increased with an increase in the Ca/Pyrophosphate ratio in the batch solution. As expected for a glass, the formation of the glassy material was demonstrated not to be thermodynamically but rather kinetically driven, and the washing step was found to be crucial to prevent crystallisation. The stability of the amorphous phase was discussed considering the structural degrees of freedom of pyrophosphate entities, ionic strength of the initial solution and the inhibitory effect of orthophosphate ions. Overall, this new strategy of preparation of monolithic calcium-(pyro)phosphate based glasses using soft chemistry in water is highly promising in view of preparing new functional organic-inorganic hybrids for bone substitution applications.
Phosphate-based glasses have gradually emerged as a potential alternative to silicate bioactive glasses in order to induce different biological mechanisms of degradation. The synthesis of such monolithic glasses at low temperature is a key step to allow new inorganic glass compositions to be reached and hybrid materials to be prepared. Although sol-gel and coacervate methods (respectively orthophosphate and metaphosphate precursors) have already been described to prepare such glasses, the use of toxic solvents and/or the final temperature treatment associated to these processes could limit the use of these materials for biomedical applications and/or the further development of hybrids. It is shown here that pyrophosphate precursors are an alternative strategy to obtain monolithic calcium (pyro)phosphate glasses under soft conditions (water solvent, 70°C).
生物活性磷酸盐玻璃的开发在生物材料科学中至关重要,特别是对于骨替代应用。在这种情况下,在低温下制备无定形的钙-磷氢氧化物/氧化物单体对于开发这些应用的新型杂化材料是一个关键挑战。本文首次报道了新型焦磷酸盐玻璃(化学式为:{[(Ca(2+))1-x(H(+)/K(+))2x]2[(P2O7(4-))1-y(PO4(3-))4y/3]} n(H2O))的合成和物理化学特性,这些玻璃是通过软化学方法在低温(T<70°C)和水溶剂下制备的。详细研究了初始 Ca/Pyrophosphate 比在这些焦磷酸盐玻璃结构和形态上的影响。根据该比值,可以获得玻璃(混合钙焦磷酸盐和正磷酸盐)或玻璃陶瓷(Ca10K4(P2O7)6·9H2O 晶体嵌入非晶相中)。随着批处理溶液中 Ca/Pyrophosphate 比的增加,结晶相的比例增加。正如预期的那样,玻璃的形成被证明不是热力学驱动的,而是动力学驱动的,并且发现洗涤步骤对于防止结晶至关重要。考虑到焦磷酸盐实体的结构自由度、初始溶液的离子强度以及正磷酸盐离子的抑制作用,讨论了非晶相的稳定性。总的来说,这种使用软化学在水中制备块状钙-(焦)磷酸盐基玻璃的新策略在制备用于骨替代应用的新型功能有机-无机杂化材料方面具有很大的前景。
磷酸盐玻璃逐渐成为生物活性硅酸盐的潜在替代品,以诱导不同的降解生物学机制。在低温下合成这种块状玻璃是一个关键步骤,可以达到新的无机玻璃成分并制备杂化材料。虽然已经描述了溶胶-凝胶和共沉淀法(分别为正磷酸盐和偏磷酸盐前体)来制备这种玻璃,但这些方法中使用的有毒溶剂和/或与这些过程相关的最终温度处理可能会限制这些材料在生物医学应用中的使用,和/或进一步发展杂化材料。本文表明,焦磷酸盐前体是在软条件下(水溶剂,70°C)获得块状钙(焦)磷酸盐玻璃的另一种策略。